A COMPARISON OF ANTIMICROBIAL ACTIVITY OF OFLOXACIN, L-OFLOXACIN, AND OTHER ORAL-AGENTS FOR RESPIRATORY PATHOGENS

被引:12
作者
CHERUBIN, CE
ENG, RHK
SMITH, SM
TAN, EN
机构
[1] INFECT DIS RES INST,JERICHO,NY
[2] DEPT VET AFFAIRS MED CTR,MED SERV,INFECT DIS SECT,E ORANGE,NJ
[3] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT MED,NEWARK,NJ 07103
[4] DEPT VET AFFAIRS MED CTR,LAB SERV,MICROBIOL SECT,E ORANGE,NJ
[5] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT LAB MED & PATHOL,NEWARK,NJ 07103
关键词
D O I
10.1016/0732-8893(92)90038-U
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The attainable inhibitory ratios (AR) for oral antibiotics were calculated by using literature reports of concentrations attained in respiratory secretions for amoxicillin-clavulanic acid (AMX/CA), ofloxacin (OFL), L-ofloxacin (L-OFL), cefuroxime (CEFU), ciprofloxacin (CIP), and enoxacin (ENO), and using microdilution minimum inhibitory concentration data of these antimicrobials against the common bacterial respiratory pathogens. AR of each antibiotic against the pathogens was expressed as multiples of the MICs achieved at the respiratory site. Bacteria tested included Staphylococcus aureus, group-A and group-B streptococci, Viridans streptococci, Streptococcus pneumoniae, Brahamella catarrhalis, Klebsiella pneumoniae, Eikenella corrodens, Haemophilus influenzae, H. parainfluenzae, Pseudomonas aeruginosa, and Legionella pneumophila. The antimicrobials with the narrowest spectrum of activity were amoxicillin-clavulanic acid and cefuroxime which had high attainable inhibitory ratios only against Gram-positive cocci. Ofloxacin and L-oflaxacin were among the quinolones with the highest overall ARs against respiratory pathogens, including, L. pneumophila, H. influenzae, and B. catarrhalis. All agents showed no, or inadequately low ARs for P. aeruginosa.
引用
收藏
页码:141 / 144
页数:4
相关论文
共 19 条
[1]  
AZADIAN BS, 1990, J ANTIMICROB CHEMOTH, V25, P771
[2]  
BERGAN T, 1981, REV INFECT DIS, V3, P45
[3]  
BERGOGNEBEREZIN E, 1983, RESPIRATORY INFECTIO, P461
[4]  
BERGOGNEBEREZIN E, 1986, MACROLIDES REV OUTLO, P43
[5]  
CHERUBIN CE, 1989, REV INFECT DIS, V11, P526
[6]   INCREASING RESISTANCE OF STAPHYLOCOCCUS-AUREUS TO CIPROFLOXACIN [J].
DAUM, TE ;
SCHABERG, DR ;
TERPENNING, MS ;
SOTTILE, WS ;
KAUFFMAN, CA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1862-1863
[7]   CEFUROXIME AXETIL IN ACUTE PURULENT EXACERBATIONS OF CHRONIC-BRONCHITIS [J].
DAVIES, BI ;
MAESEN, FPV ;
TEENGS, JP .
INFECTION, 1987, 15 (04) :253-256
[8]   SERUM AND SPUTUM CONCENTRATIONS OF ENOXACIN AFTER SINGLE ORAL DOSING IN A CLINICAL AND BACTERIOLOGICAL STUDY [J].
DAVIES, BI ;
MAESEN, FPV ;
TEENGS, JP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :83-89
[9]   THE QUINOLONES IN CHRONIC-BRONCHITIS [J].
DAVIES, BI ;
MAESEN, FPV ;
TEENGS, JP ;
BAUR, C .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1986, 8 (01) :53-59
[10]   A DOUBLE-BLIND RANDOMIZED STUDY COMPARING OFLOXACIN AND AMOXICILLIN IN TREATING INFECTIVE EPISODES IN BRONCHIECTASIS [J].
LAM, WK ;
CHAU, PY ;
SO, SY ;
LEUNG, YK ;
CHAN, JCK ;
SHAM, MK .
INFECTION, 1986, 14 :S290-S292